Perrigo pushes into Europe with Omega deal
10 November 2014
Get up to speed on Perrigo's plans with Omega Pharma on board through this NEWS EXTRA from OTCToolbox, which focuses on Perrigo's US$4.5 billion acquisition of the Belgian OTC firm.
News Extras
OTCToolbox News Extra publications provide you with rapid insights into developments in the consumer healthcare/OTC industry worldwide. They can be purchased and downloaded immediately. They are also available as part of an Annual Subscription to the OTCToolbox website.
Insight pushes Prestige towards billion dollars
18 September 2014
Gain rapid insights into Prestige Brands Holdings' strategy with this NEWS EXTRA, which looks at the firm's OTC acquisitions, international growth, innovations and future plans.
Meda boosts OTC with Rottapharm Madaus deal
8 August 2014
Get up to speed with Meda's OTC strategy following the news that the Swedish company is acquiring Italy's Rottapharm Madaus in a deal worth SEK21.2 billion (US$3.08 billion).
Bayer has big plans following Merck OTC deal
8 May 2014
Bayer has agreed to acquire US Merck & Co's Consumer Care business for US$14.2 billion after a "highly-contested quest for a crown jewel", and has big plans for the brands outside the US.
GSK and Novartis unveil "unusual" OTC deal
23 April 2014
GlaxoSmithKline and Novartis have agreed to combine their global consumer healthcare operations into a world-leading business with annual sales of £6.5 billion (US$10.9 billion).
US scrutinises OTC monograph process
9 April 2014
A wide range of suggestions for changing the US OTC drug review were put forward by speakers at a recent public hearing organised by the Food and Drug Administration (FDA).
Perrigo expands in US, abroad and online
19 March 2014
Perrigo is expanding outside the US, capitalising on e-commerce through Amazon, entering adjacent product categories, and building value brands as well as store brands.
Private-equity deal highlights Atrium’s ambitions
4 December 2013
News that Canada's Atrium Innovations is set to be acquired by a group of investors, including private-equity firm Permira, shows the ambitions of the dietary supplements company.
Stada strikes two deals in quick succession
22 October 2013
Germany’s Stada Arzneimittel has demonstrated its OTC ambitions by striking two deals in quick succession. Deborah Wilkes reports on the German generics company's business strategy.
Bayer maps route to global top spot in OTC
4 July 2013
Global brand expansion, innovation, emerging market growth and bolt-on acquisitions can make Bayer Consumer Care the world's number one OTC player, says worldwide head Erica Mann.